Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Newsweek ranked the 50 best heart hospitals in the world

Deaths from CVD are on the rise, cardiologists warn—high blood pressure, obesity remain 2 primary culprits

Cardiovascular disease remains one of the leading causes of mortality in the world, responsible for nearly 20 million deaths in 2022 alone. 

 deep-penetrating acoustic volumetric printing 3D printing

New 3D-printing technique shows early potential to help heart patients

“We can reach tissues, bones and organs with high spatial precision that haven’t been reachable with light-based printing methods," one researcher explained. 

Thumbnail

FDA announces recall of Cardiohelp ECMO emergency drives due to serious risks

If the emergency drive is needed during treatment, it could fail to work, putting patients at risk of ischemia, hypoxia, stroke or death.

business launch

Venture capital firm raises $90M, launches new AFib ablation company

According to Ajax Health CEO and industry veteran Duke Rohlen, the new company will be focused on offerings that "prioritize precision, simplicity and efficiency."

artificial intelligence money finance acquisition

Medtronic backs out of $738M acquisition due to ‘multiple breaches’

Medtronic confirmed its decision in a statement, but did not provide any specific details. The deal was originally announced in May.

Harlan M. Krumholz, MD, Yale American College of Cardiology

American College of Cardiology names renowned cardiologist the next editor-in-chief of its flagship journal

The publication's current editor-in-chief is Valentin Fuster, MD, PhD. Harlan M. Krumholz, MD, will begin his five-year term in 2024.

Dapagliflozin improves symptoms in some, but not all, heart failure patients

The popular SGLT2 inhibitor, sold under the brand name Farxiga, is approved by the FDA to treat heart failure, type 2 diabetes and CKD. Recent data on its ability to affect the symptoms of heart failure patients have been inconsistent. 

Cardiac imaging expert Renee Bullock-Palmer, MD, explains how calcium scoring can determine if patients need to be on statins or not.

CT calcium scoring can determine if patients need statins

Renee Bullock-Palmer, MD, director, non-invasive cardiac imaging, at the Deborah Heart and Lung Center, explains CT calcium scoring can determine if a patient needs to take aspirin and statins for prevention of coronary disease.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.